Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue Suppl 1
926 BAY 2965501: a highly selective DGK zeta inhibitor for cancer immunotherapy
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Immune Cell Types and Biology
926 BAY 2965501: a highly selective DGK zeta inhibitor for cancer immunotherapy
Online download statistics by month:
Online download statistics by month: November 2023 to June 2025
Abstract
Full
Pdf
Nov 2023
260
0
35
Dec 2023
142
0
37
Jan 2024
101
0
17
Feb 2024
162
0
43
Mar 2024
242
0
43
Apr 2024
261
0
41
May 2024
174
0
30
Jun 2024
232
0
39
Jul 2024
210
0
19
Aug 2024
238
0
30
Sep 2024
230
0
34
Oct 2024
394
0
45
Nov 2024
334
0
58
Dec 2024
296
0
48
Jan 2025
344
0
31
Feb 2025
116
0
70
Mar 2025
0
0
58
Apr 2025
0
0
71
May 2025
1
0
32
Jun 2025
0
0
20
Total
3737
0
801
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF